Compare Medtronic PLC (MDT) vs Invesco Preferred ETF (PGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Invesco Preferred ETF — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while Invesco Preferred ETF trades at $10.01 (market cap $3.60B). The key difference: Medtronic PLC is far larger — about 31.2× Invesco Preferred ETF's market cap, and Medtronic PLC pays a 3.28% dividend while Invesco Preferred ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Invesco Preferred ETF for 95 Days on average.
| MDT | PGX | |
|---|---|---|
Market Cap | $112.24B | $3.60B |
Volume | 105,663,236 | 5,986,026 |
Sector | Health | — |
52-Week High | $105.35 | $11.61 |
52-Week Low | $73.75 | $9.97 |
Typical Hold Time | 63 Days | 95 Days |
Enterprise Value | $131.58B | — |
Dividend Yield | 3.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong fundamental performance including three consecutive quarterly earnings beats and a 49-year dividend growth streak. The stock shows bearish technical signals but maintains solid profitability with 13.93% net margins and positive cash flow trends. Recent regulatory approvals for medical devices and raised guidance signal operational momentum despite mixed technical indicators.
Outlook remains positive with analyst consensus at $97.80 (11% upside) and no sell ratings, though technical weakness and increasing debt-to-asset ratios pose near-term risks. The 3.2% dividend yield provides income support while revenue growth acceleration to $37.5B projected for 2026 offers growth potential.
PGX trades at $10.03, up 0.6% today, with a bearish technical outlook as moving averages signal strong selling pressure. Key support and resistance cluster at $10. The company has scheduled dividends for July and September 2026 at $0.06 per share, but financial ratios like P/E and P/S are unavailable, limiting fundamental visibility.
The stock faces headwinds from weak technical momentum and a lack of current financial data, though dividend payments provide some income appeal. Risks include reliance on outdated metrics and market sensitivity. Investors need updated earnings reports to assess valuation and growth prospects accurately.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Invesco Preferred ETF
The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects securities for the index, which is a market capitalization-weighted index designed to measure the performance of the fixed rate US dollar-denominated preferred securities market.
Read more on PGX →
